Qualitest Pharmaceuticals Issues Recall For All Accusure® Insulin SyringesOct 28, 2009 | Parker Waichman LLP
A voluntary nationwide recall was issued yesterday for all Accusure® Insulin Syringes manufactured by Qualitest Pharmaceuticals of Huntsville, Alabama.
The recalled syringes may have needles which detach from the syringe. According to the recall notice, if the needle becomes detached from the syringe during use, it can become stuck in the insulin vial, push back into to the syringe, or remain in the skin after injection.
The distributed syringes are of the following descriptions and NDC numbers:
28G 1/2cc, NDC 0603-6995-21
28G 1cc, NDC 0603-6996-21
29G 1/2cc NDC 0603-6997-21
29G 1cc, NDC 0603-6998-21
30G 1/2cc, NDC 0603-999-21
30G 1cc, NDC 0603-7000-21
31G 1/2cc, NDC 0603-7001-21
31G 1cc, NDC 0603-7002-21
All Accusure® Insulin Syringes regardless of lot number are subject to this recall. These syringes were distributed between January 2002 and October 2009 to wholesale and retail pharmacies nationwide (including Puerto Rico).
Consumers who have any Accusure® Insulin Syringes should stop using them and contact Qualitest at 1-800-444-4011 for reimbursement. Qualitest is notifying all customers who received these syringes and arranging for the return of any affected product.